Design plays a pivotal role in the realm of 3D-printed medical devices, serving as a linchpin in ensuring safety, efficacy, and innovation. The unique capabilities of 3D printing technology allow for the creation of highly customized and intricate medical devices, tailored to the specific needs of individual patients or medical applications. An effective design process ensures that these devices not only meet their intended functions but also adhere to critical standards of biocompatibility, sterilization, and regulatory compliance. Precise design optimization can significantly reduce material waste, production time, and costs while enhancing the overall performance of these devices, making them more accessible and affordable to a wider range of patients and healthcare providers. Moreover, design innovation in 3D-printed medical devices can address unmet medical needs and improve patient outcomes. Customization is a hallmark of 3D printing, allowing for patient-specific implants, prosthetics, and anatomical models for surgical planning. Furthermore, the technology enables the integration of complex features such as lattice structures, drug delivery systems, and biomimetic designs that were previously unattainable through traditional manufacturing methods. In research and development, 3D printing facilitates rapid prototyping, enabling iterative testing and refinement, ultimately leading to breakthroughs in medical device functionality and performance. Thus, an emphasis on thoughtful and creative design in 3D printing for medical devices is paramount in advancing the healthcare industry, improving patient care, and driving innovation in the field. In this upcoming virtual event, 3DHEALS invites you to join a panel of design experts and startup founders to explore the future of DfAM (Design for Additive Manufacturing).
Apply to speak or sponsor the event: firstname.lastname@example.org
Nicholas Jacobson is trained as both an architect and a computational designer. He has a particular interest in a technically synthetic and logically rigorous approach to form and fabrication. As a practiced architect and designer, he has designed buildings for the aerospace industry, concert halls, ultra-high-end residential, operating rooms, and structures in extreme environments. Currently, he researches and develops novel methods and tools for complex surgeries leveraging disparate computational methods from numerous fields including Architecture, Animation, Fashion, Regenerative Medicine, and Structural Engineering. This work focuses on three areas of patient-specific focused development: Diagnostics, Prosthetics, and Implants. His work and research have been published in books, scholarly journals, magazines, and newspapers; these include: ACADIA, AD, CAADRIA, Code LA, Huffington Post, Modern Luxury, Nature, New York Times, Popular Science, Sky News, and Vogue and shown work both nationally and internationally. He has lectured at Harvard University, Stanford University, University of North Carolina, and the University of Denver and for companies such as AutoDesk, Zaha Hadid Architects, Medtronic, Edwards Lifesciences, Thornton Tomasetti, Stratasys, Trimble, and the Keynote speaker for AMUG 2023. He received a Bachelor’s in Architecture (Summa Cum Laude) from the University of Wisconsin SARUP and an M.Des (Design Technology) from Harvard GSD and the Harvard Business School.
Gilly is a biomedical engineer, inventor, and an operations leader with 20 years of medical device industry and scientific research experience, and currently is the founder and CEO of Vent Creativity Corporation, an AI based digital twin surgical planning and decision-making software serving the orthopaedics and healthcare community. Gilly started his career in industrial robotic automation, and then translated this knowledge to human biomechanics, design, testing, and regulatory filing of medical devices. Gilly previously advised a multi-billion-dollar industry on product portfolio needs and M&A considerations for multiple $5MM+ NPV projects. He also advised C-level executives for their medical device regulatory and business strategy needs. Gilly has been instrumental in the regulatory testing, documentation, and filing aspects of 13 Class II, 1 IDE, and 1 IND FDA medical device products. Gilly has over 25 peer reviewed published articles in the orthopaedic medical device field. Gilly holds 13 published or granted patents in the field of big-data driven surgery, additive manufacturing for medical devices, and robotic surgery, and presented foundational research at various peer-reviewed conferences and publications. Gilly holds a Bachelor of Science in Industrial Engineering from NJIT, a Master of Science in Biomedical Engineering and an MBA from Columbia University.
Elissa Ross is a mathematician and the CEO of Toronto-based startup Metafold 3D. Metafold makes an engineering design platform for additive manufacturing, with an emphasis on supporting engineers using metamaterials, lattices and microstructures at industrial scales. Elissa holds a PhD in discrete geometry (2011), and worked as an industrial geometry consultant for the 8 years prior to cofounding Metafold. Metafold is the result of observations made in the consulting context about the challenges and opportunities of 3D printing.
Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.